J9205 Injection irinotecan liposome 1 milligrams
Also known as: irinotecan liposome, Nal-IRI, Onivyde
Intravenous injection of irinotecan liposome, a liposomal formulation of irinotecan topoisomerase I inhibitor, dosed per 1 milligram.
In Plain Language
liposomal colon cancer drug; liposomal chemotherapy
Clinical Context
Used for metastatic pancreatic cancer and other solid tumors with enhanced tolerability versus standard irinotecan.
RVU Information
CPT J9205 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9205?
CPT J9205 (Injection irinotecan liposome 1 milligrams) is a J Codes (Drugs) code. Intravenous injection of irinotecan liposome, a liposomal formulation of irinotecan topoisomerase I inhibitor, dosed per 1 milligram.
How is J9205 administered?
CPT J9205 is administered by a healthcare provider, typically via injection or infusion. Used for metastatic pancreatic cancer and other solid tumors with enhanced tolerability versus standard irinotecan. It is used by Oncology, Medical Oncology.
When is CPT J9205 used?
Used for metastatic pancreatic cancer and other solid tumors with enhanced tolerability versus standard irinotecan.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.